Recombinant Protein Production in Mammalian and Insect Cells

Displaying 1 - 5 of 5CSV
Shahid, S., Prockop, S. E., Flynn, G. C., Mauguen, A., White, C., Bieler, J., McAvoy, D., Hosszu, K., Cancio, M. I., Jakubowski, A. A., Scaradavou, A., Boelens, J. J., Sauter, C. S., Perales, M.-A., Giralt, S. A., Taylor, C., Chaudhari, J., Wang, X., Rivière, I., … Curran, K. J. (2025). Allogeneic Off-the-Shelf CAR T-Cell Therapy for Relapsed or Refractory B-Cell Malignancies. Blood Advances. https://doi.org/10.1182/bloodadvances.2024015157
Publication Date
Feldmann, C., Schänzler, M., Ben-Johny, M., & Wahl-Schott, C. (2023). Protocol for deriving proximity, affinity, and stoichiometry of protein interactions using image-based quantitative two-hybrid FRET. STAR Protocols, 4(3), 102459. https://doi.org/10.1016/j.xpro.2023.102459
Publication Date
Stefanski, H. E., Eaton, A., Baggott, C., Rossoff, J., Verneris, M. R., Prabhu, S., Pacenta, H. L., Phillips, C. L., Talano, J.-A., Moskop, A., Margossian, S. P., Myers, G. D., Karras, N. A., Brown, P. A., Qayed, M., Hermiston, M., Satwani, P., Krupski, M. C., Keating, A. K., … Schultz, L. M. (2023). Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium. Blood Advances, 7(4), 541–548. https://doi.org/10.1182/bloodadvances.2022007246
Publication Date